Taiwan Liposome Company, Ltd. (TLC) has an overall financial health rating of B with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2021-10-06.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2021-10-06 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2021-10-05 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2021-10-04 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2021-10-01 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2021-09-30 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2021-09-29 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2021-09-28 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2021-09-27 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2021-09-24 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2021-09-23 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2021-09-22 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2021-09-21 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
